Dr. Tann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
714 N Senate Ave
Ste 250
Indianapolis, IN 46202Phone+1 317-715-6402Fax+1 317-715-6415
Education & Training
- Indiana University School of MedicineResidency, Nuclear Medicine, 2000 - 2002
- Ben Gurion University of the NegevClass of 1994
Certifications & Licensure
- IN State Medical License 2002 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver Start of enrollment: 2017 Aug 17
Publications & Presentations
PubMed
- 18 citationsEstimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancerMark A. Green, Jacob A. Eitel, James W. Fletcher, Carla J. Mathias, Mark Tann
Nuclear Medicine and Biology. 2017-03-01 - 2 citationsComparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer ...Clinton D Bahler, Isamu Tachibana, Mark Tann, Katrina Collins, Jordan K Swensson
The Journal of Urology. 2024-08-01 - 6 citationsCT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis.Milan Patel, Mark Tann, Suthat Liangpunsakul
The American Journal of the Medical Sciences. 2021-09-01
Journal Articles
- CT Texture Analysis of Pancreatic CancerMark Tann, MD, European Radiology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: